Consider the Risk:
A Case-based Look at Risk
Assessment in PAH Management

Sunday, May 20, 2018

6:30 PM–7:00 PM Registration and Dinner
7:00 PM–8:30 PM Symposium

Agenda and Faculty

Welcome and Introductions
Vallerie McLaughlin, MD, Chair
University of Michigan
Ann Arbor, Michigan

Overview of PAH
Vallerie McLaughlin, MD
Current Considerations About
Clinical Decision-Making in PAH

Vallerie McLaughlin, MD
Evaluating Risk in a Previously
Diagnosed IPAH Patient:
Case Study and Discussion

Nick H. Kim, MD
University of California, San Diego
La Jolla, California
Evaluating Risk in a Previously
Diagnosed PAH-CTD Patient:
Case Study and Discussion

Lana Melendres-Groves, MD
University of New Mexico School of Medicine
Albuquerque, New Mexico
Panel Discussion
All Faculty

Concluding Remarks
Vallerie McLaughlin, MD
Hilton San Diego Bayfront

Indigo Ballroom A/E
Second Floor
1 Park Boulevard
San Diego, California
This promotional program is sponsored by Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
Dinner will not be provided to physicians and other healthcare professionals licensed in Vermont or other states where gifts and meals are prohibited. Dinner provided to physicians will be subject to reporting under Federal law. Federal, state, and local government employees should abide by their respective meal limits. We regret that spouses and other guests cannot be accommodated.
An Industry-Organized Symposium at the ATS 2018 International Conference. A non-CME educational program sponsored by Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, open to all ATS 2018 International Conference attendees.